Mediark

Mediark is developer of a biopharmaceutical delivery platform intended to caters biomaterials and pharmaceutical businesses.

Mediark operates in deeptech based in Tokyo, Japan, founded in 2019.

Profile

Mediark possesses innovative porous material technology and develops innovative products in the chemical/biotechnology fields through this. In addition to nano/micro particle size control, we are developing adsorbents, catalysts, vaccines, targeted therapeutics, and synthetic drugs through pore control/surface modification/drug loading technology and are striving to commercialize them.

Within the deeptech space, the company focuses on its core offering rather than a broad product line.

Tokyo, Japan is where the company is located.

Its current recorded stage is Plug and Play portfolio startup.

Its team size is recorded as 1-10 employees.

Website: www.mediark.kr/main